Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard A Fox

Showing results (51-60 of 158) with videos related to

Pageof 16
Sort By:
Journal of Translational Medicine|April 22, 2023
The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022Paolo A Ascierto, Renier Brentjens, Samir N Khleif, et al.
Scientific Reports|November 23, 2016
Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor RegressionGuangjie Yu, Yuhuan Li, Zhihua Cui, et al.
The Analyst|August 23, 2022
A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeuticsNoriko Iwamoto, Yoshinobu Koguchi, Kotoko Yokoyama, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 26, 2007
Induction of circulating tumor-reactive CD8+ T cells after vaccination of melanoma patients with the gp100 209-2M peptideSybren L Meijer, Annemieke Dols, Shawn M Jensen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2012
Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrenceShawn M Jensen, Christopher G Twitty, Levi D Maston, et al.
Oral Oncology|September 12, 2016
Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapyR Bryan Bryan, Michael J Gough, Steven K Seung, et al.
Cancer Research|November 17, 2005
Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editingLi-Xin Wang, Rui Li, Guojun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of LymphodepletionSinnie Sin Man Ng, Bethany A Nagy, Shawn M Jensen, et al.
Journal of Translational Medicine|March 5, 2013
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatmentPaolo A Ascierto, Mariaelena Capone, Walter J Urba, et al.
Journal for Immunotherapy of Cancer|October 27, 2015
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanomaZipei Feng, Sachin Puri, Tarsem Moudgil, et al.
Pageof 16

Showing results (51-60 of 158) with videos related to

Sort By:
Pageof 16
Journal of Translational Medicine|April 22, 2023
The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022Paolo A Ascierto, Renier Brentjens, Samir N Khleif, et al.
Scientific Reports|November 23, 2016
Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor RegressionGuangjie Yu, Yuhuan Li, Zhihua Cui, et al.
The Analyst|August 23, 2022
A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeuticsNoriko Iwamoto, Yoshinobu Koguchi, Kotoko Yokoyama, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 26, 2007
Induction of circulating tumor-reactive CD8+ T cells after vaccination of melanoma patients with the gp100 209-2M peptideSybren L Meijer, Annemieke Dols, Shawn M Jensen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2012
Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrenceShawn M Jensen, Christopher G Twitty, Levi D Maston, et al.
Oral Oncology|September 12, 2016
Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapyR Bryan Bryan, Michael J Gough, Steven K Seung, et al.
Cancer Research|November 17, 2005
Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editingLi-Xin Wang, Rui Li, Guojun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of LymphodepletionSinnie Sin Man Ng, Bethany A Nagy, Shawn M Jensen, et al.
Journal of Translational Medicine|March 5, 2013
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatmentPaolo A Ascierto, Mariaelena Capone, Walter J Urba, et al.
Journal for Immunotherapy of Cancer|October 27, 2015
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanomaZipei Feng, Sachin Puri, Tarsem Moudgil, et al.
Pageof 16